Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases.
Ontology highlight
ABSTRACT: The eukaryotic pathogens Trypanosoma brucei, Trypanosoma cruzi and Leishmania are responsible for debilitating diseases that affect millions of people worldwide. The numbers of drugs available to treat these diseases, Human African Trypanosomiasis, Chagas' disease and Leishmaniasis are very limited and existing treatments have substantial shortcomings in delivery method, efficacy and safety. The identification and validation of novel drug targets opens up new opportunities for the discovery of therapeutic drugs with better efficacy and safety profiles. Here, the potential of targeting the ubiquitin-proteasome system in these parasites is reviewed. Ubiquitination is the posttranslational attachment of one or more ubiquitin proteins to substrates, an essential eukaryotic
SUBMITTER: Bijlmakers MJ
PROVIDER: S-EPMC7958763 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA